Acadian Asset Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,180	Closed	-$34K	–	1673
2023 Q3	$34K	Buy	+1,180	New	+$34K	﹤0.01%	1466
2018 Q2	–	Sell	-19	Closed	-$229K	–	1698
2018 Q1	$229K	Sell	19 -2	-10%	-$24.1K	﹤0.01%	1029
2017 Q4	$194K	Buy	+21	New	+$194K	﹤0.01%	964